Reneo Pharmaceuticals Stock Forecast - Double Exponential Smoothing

RPHM Stock  USD 1.68  0.01  0.59%   
The Double Exponential Smoothing forecasted value of Reneo Pharmaceuticals on the next trading day is expected to be 1.68 with a mean absolute deviation of  0.03  and the sum of the absolute errors of 1.49. Reneo Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Reneo Pharmaceuticals stock prices and determine the direction of Reneo Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Reneo Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Historical Fundamental Analysis of Reneo Pharmaceuticals to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
  
Most investors in Reneo Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Reneo Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Reneo Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for Reneo Pharmaceuticals works best with periods where there are trends or seasonality.

Reneo Pharmaceuticals Double Exponential Smoothing Price Forecast For the 26th of April

Given 90 days horizon, the Double Exponential Smoothing forecasted value of Reneo Pharmaceuticals on the next trading day is expected to be 1.68 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.49.
Please note that although there have been many attempts to predict Reneo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Reneo Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Reneo Pharmaceuticals Stock Forecast Pattern

Backtest Reneo PharmaceuticalsReneo Pharmaceuticals Price PredictionBuy or Sell Advice 

Reneo Pharmaceuticals Forecasted Value

In the context of forecasting Reneo Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Reneo Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 3.60, respectively. We have considered Reneo Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.68
1.68
Expected Value
3.60
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Reneo Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Reneo Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information CriteriaHuge
BiasArithmetic mean of the errors -0.0047
MADMean absolute deviation0.0252
MAPEMean absolute percentage error0.0151
SAESum of the absolute errors1.4869
When Reneo Pharmaceuticals prices exhibit either an increasing or decreasing trend over time, simple exponential smoothing forecasts tend to lag behind observations. Double exponential smoothing is designed to address this type of data series by taking into account any Reneo Pharmaceuticals trend in the prices. So in double exponential smoothing past observations are given exponentially smaller weights as the observations get older. In other words, recent Reneo Pharmaceuticals observations are given relatively more weight in forecasting than the older observations.

Predictive Modules for Reneo Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reneo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reneo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.683.60
Details
Intrinsic
Valuation
LowRealHigh
0.071.413.33
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Reneo Pharmaceuticals. Your research has to be compared to or analyzed against Reneo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Reneo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Reneo Pharmaceuticals.

Other Forecasting Options for Reneo Pharmaceuticals

For every potential investor in Reneo, whether a beginner or expert, Reneo Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Reneo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Reneo. Basic forecasting techniques help filter out the noise by identifying Reneo Pharmaceuticals' price trends.

View Reneo Pharmaceuticals Related Equities

 Risk & Return  Correlation

Reneo Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Reneo Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Reneo Pharmaceuticals' current price.

Reneo Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Reneo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reneo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reneo Pharmaceuticals stock market strength indicators, traders can identify Reneo Pharmaceuticals entry and exit signals to maximize returns.

Reneo Pharmaceuticals Risk Indicators

The analysis of Reneo Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reneo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reneo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Reneo Pharmaceuticals is a strong investment it is important to analyze Reneo Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reneo Pharmaceuticals' future performance. For an informed investment choice regarding Reneo Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Reneo Pharmaceuticals to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Complementary Tools for Reneo Stock analysis

When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.